In an attempt to understand the abnormal regulation of calcium metabolism in these animals, we examined the expression of calbindins (CaBP) as well as calcium handling in the intestine and kidney of VDR null mice. In adult VDR-null mice, intestinal and renal CaBP-D9k expression was reduced by 50 and 90%, respectively, at both the mRNA and protein levels compared with wild-type littermates, whereas renal CaBP-D28k expression was not significantly changed. Intestinal calcium absorption was measured by the rate of 45 Ca disappearance from the intestine after an oral dose of the isotope.
45
Ca absorption was similar in VDR-null and wildtype mice, but the amount of 45 Ca accumulated in the serum and bone was 3-4 times higher in wild-type mice than in VDR-null mice. Despite the hypocalcemia, the urinary excretion of calcium in VDR-null mice was not different from that in wild-type mice. Moreover, 1 wk of a high-calcium diet treatment that normalized the serum ionized calcium level of VDR-null mice increased the urinary calcium level of these mutant mice to twofold higher than that of wild-type mice on the same diet, suggesting impaired renal calcium conservation in VDR-null mice. These data demonstrate that renal CaBP-D9k, but not CaBP-D28k, is highly regulated by the VDR-mediated action of 1,25-dihydroxyvitamin D3. Furthermore, the results also suggest that impaired calcium conservation in the kidney may be the most important factor contributing to the development of hypocalcemia in VDR-null mice, and CaBP-D9k may be an important mediator of calcium reabsorption in the kidney.
calbindin-D9k; calbindin-D28k; 1,25-dihydroxyvitamin D3; calcium absorption; calcium excretion CALBINDIN (CaBP), the vitamin D-dependent calciumbinding protein, is believed to be involved in the ATPdependent transcellular calcium transport in the epithelia of the intestine and renal distal tubules (13, 14, 26) . Two classes of CaBP have been identified in animals. CaBP-D9k is a 9,000-Da cytosolic protein expressed mainly in mammalian intestine and kidney, and CaBP-D28k is a 28,000-Da protein highly expressed in mammalian kidney and avian intestine (14) .
CaBP-D9k and CaBP-D28k have also been detected in other tissues, including the brain, uterus, eggshell gland, placenta, lung, and pancreas (14) , but their functions in these tissues are far less clear. Encoded by two different genes, both CaBP-D9k and CaBP-D28k have been shown to be induced transcriptionally by 1,25-dihydroxyvitamin D 3 [1, 25(OH) 2 D 3 ], the most active metabolite of vitamin D, in animals and in cell and organ cultures (8, 19, 20, 23, 25, 29, 35, 42, 43) . Most recent studies suggest that the regulation of CaBPD9k gene expression is complex, involving both vitamin D and other transcriptional factors (5, 17) .
We showed previously (31) that mice with a disrupted vitamin D receptor (VDR) had impaired calcium homeostasis with hypocalcemia, rickets, and osteomalacia, but the relative contribution of intestinal and renal calcium metabolism to the development of impaired calcium homeostasis remains unknown. Because CaBPs have been implicated in intestinal and renal calcium transport (13, 26) , we examined the expression of CaBPs as well as intestinal and renal calcium handling in VDR-null mice. Although we have reported previously that VDR inactivation results in reduced CaBP-D9k mRNA and almost normal CaBPD28k mRNA levels (32) , the level of these proteins in target tissues was not previously determined. Here, we further quantify both the mRNA and protein expression of CaBP-D9k and CaBP-D28k in VDR-null and wild-type mice. Our data indicate that CaBP-D9k, but not CaBP-D28k, is highly regulated by the VDR-mediated action of 1,25(OH) 2 D 3 and suggest that impaired renal calcium conservation is the major contributor to the sustained hypocalcemia in VDR-null mice.
MATERIALS AND METHODS
Animal maintenance and treatment. All animal protocols were approved by the Institutional Animal Use and Care Committee. Generation and characterization of VDR-null mice were reported previously (31) . Mice were housed in a virus-and parasite-free barrier facility, exposed to a 12:12-h light-dark cycle, and fed an autoclaved rodent diet containing 1% calcium, 0.85% phosphorus and 4 IU/g vitamin D 3 . VDR(-/-) and wild-type mice were produced through breeding of heterozygous mice and identified by PCR with the use of tail genomic DNA. The phenotype of VDR(-/-) mice is the same as that previously reported (31) , with the blood ionized calcium level 25-30% lower than that of the wild-type littermates (0.92 Ϯ 0.04 mM vs. 1.23 Ϯ 0.05 mM). For dietary treatment, 2-3 mo old, sex-matched VDR(-/-) and wild-type littermates were fed a special diet that contained 2% calcium, 1.25% phosphorus, 4 IU/g vitamin D 3, and 20% lactose (HCaLac diet; Teklad, Madison, WI) for 1 wk. This diet was previously shown to normalize the serum ionized calcium in VDR(-/-) mice (30) .
Measurement of blood and urinary parameters. Blood was collected through heart puncture under anesthesia into a tube containing heparin. Blood ionized calcium concentration was determined using a NOVA-2 pH/Calcium analyzer (Nova Biomedical, Waltham, MA). To measure urinary calcium, mice were placed in individual metabolic cages with adequate access to water and food, and urine was collected for 24 h. Urinary content of calcium, phosphate, and creatinine was determined using a Beckman Coulter CX5 Autoanalyzer calibrated with the urinary chemistry controls (Medical Analysis System). The mineral concentration was normalized to urinary creatinine.
Measurement of intestinal calcium absorption. Intestinal calcium absorption was determined according to the method described previously (34) with modifications. Briefly, 3-moold VDR(-/-) and wild-type mice were fasted overnight. The mice were then administered 0.2 ml of 50 mM CaCl 2 containing 1 C 45 CaCl2 by oral gavage. Mice (3 pairs at each time point) were killed at 0, 90, 180, and 360 min after 45 Ca administration, and blood, femurs, and gastrointestinal tracts from esophagus to anus were collected. The blood was left at 4°C overnight, and serum was collected through centrifugation. The femurs and intestines were homogenized in 2 and 10 ml of distilled deionized water, respectively, with a Polytron homogenizer (Brinkmann, Westbury, NY), and 0.5 ml of homogenates was mixed with 2 ml of NCS-II tissue solubilizer (Amersham, Piscataway, NJ) in scintillation vials. The mixture was incubated at 50°C overnight and mixed with 30 l of acetic acid and 18 ml of ScintiSafe plus 50% scintillation cocktail (Fisher Scientific, Turnberry, IL). The sera (0.1 ml) were mixed with NCS-II according to the manufacturer's instruction. Radioactivity was measured by counting for 5 min in a TRI-CARB 1500 liquid scintillation analyzer (Packard, Meriden, CT).
RNA isolation and Northern blot. After the mice were killed, the duodena and kidneys were dissected and placed in TRIzol solution (Life Technologies, Grand Island, NY) and homogenized immediately with a Polytron probe (Brinkmann). Total RNA was isolated according to the manufacturer's instructions. For Northern analysis, total RNA (20 g/ lane) was separated on a 1.2% agarose gel containing 2.2 M formaldehyde (3) and transferred onto a Nylon membrane (MSI, Westborough, MA). Hybridization was performed according to the method described by Church and Gilbert (15) . cDNA probes for CaBP-D9k and CaBP-D28k were labeled with [
32 P]dATP by use of the Prime-a-gene labeling system (Promega, Madison, WI). Properly washed membranes were exposed to X-ray films at Ϫ80°C for autoradiography. The relative amount of mRNA was quantitated using a PhosphoImager (Molecular Dynamic, Sunnyvale, CA). Variations in RNA loading were normalized with 36B4 RNA, the acidic ribosomal phosphoprotein PO (27) .
Western blot. Freshly dissected duodena and kidneys were placed into ice-cold sample buffer (38) , boiled for 5 min, and sonicated for 1 min with a Branson microprobe (Branson, Danbury, CT). After sonication, the samples were boiled for an additional 3 min and centrifuged to remove insoluble materials. Protein concentration was determined using the Amido black method (37) . Proteins were resolved by SDS-PAGE according to Laemmli (28) . For CaBP-D9k detection, proteins were separated on a 16.5% gel in a Tricine system according to Schagger and von Jagow (38) , with purified bovine CaBP-D9k as a standard (Sigma, St. Louis, MO). The conventional glycine-based SDS-PAGE system (12% gel) was used for CaBP-D28k and VDR detection. Purified recombinant rat CaBP-D28k (Swant, Bellinzona, Switzerland) and human VDR (a gift from Dr. J. Wesley Pike, University of Cincinnati) were used as respective standards. For Western analysis, the separated proteins were transblotted onto an Immobilon-P membrane (Millipore, Bedford, MA) at 45 mA overnight according to Towbin et al. (41) with the use of a minigel transfer apparatus (Hoefer). The membranes were stained with 0.05% India ink to confirm equal protein loading and transfer. The membranes were then blocked with Trisbuffered saline containing 0.05% Tween-20 and 5% dry milk and were incubated sequentially with primary and secondary antibodies dissolved in the same solution for 1 h at room temperature. Polyclonal anti-VDR antibody was purchased from Santa Cruz Biotechnology (Santa Cruz, CA) (used at 1:1,000 dilution), polyclonal anti-CaBP-D9k antibody was from Swant (used at 1:10,000 dilution), polyclonal antiCaBP-D28k antibody was from Chemicon International (Temecula, CA) (used at 1:10,000 dilution), and horseradish peroxidase-conjugated goat anti-rabbit IgG was from K&P Laboratories (Gaithersburg, MD) (used at 1:10,000 dilution). The protein recognized by the antibody was visualized using a LumiGLO chemiluminescent substrate kit (K&P Laboratories), according to the manufacturer's instructions. Antigen was quantified by scanning of the xerograms with a Umax Power Look II scanner (Umax Data Systems, Taipei, Taiwan) followed by image processing by IP Lab Gel software.
Statistical analysis. Data are presented as means Ϯ SD. Student's t-test was used to identify significant differences. P values Յ0.05 were considered to be statistically significant. Figure 1 shows representative Western and Northern blots of VDR, CaBP-D9k and CaBP-D28k protein and mRNA in 3-mo-old wild-type and VDR-null mice. As expected, no VDR protein was detected in the intestine and kidney of VDR(-/-) mice (Fig. 1, A and C) . Expression of duodenal and renal CaBP-D9k in VDR(-/-) mice was substantially decreased at both the protein and mRNA levels, whereas CaBP-D28k expression was essentially unchanged in the mutant mice. It is of note that renal CaBP-D9k was barely detectable in VDR(-/-) mice. Figure 2 shows the expression of CaBPD9k and CaBP-D28k in mice at different ages. Overall, the expression of both CaBP-D9k and CaBP-D28k mRNA and protein in wild-type mice tended to decline with age, but the levels in VDR(-/-) mice were unchanged. Thus significant differences in duodenal CaBP-D9k and renal CaBP-D28k expression between wild-type and VDR(-/-) mice were seen in younger, but not in older, animals (Fig. 2, A, B, E and F) . In contrast, both the protein and mRNA levels of renal CaBP-D9k in VDR(-/-) mice were ϳ10% of the wild-type levels at all age groups (Fig. 2, C and D) , indicating that VDR is a dominant regulator for renal CaBP-D9k expression.
RESULTS

Effect of VDR inactivation on expression of CaBPs in intestine and kidney.
Effect of age on expression of CaBPs in VDR(-/-) and wild-type mice.
Similar results were obtained in 6-mo-old animals (data not shown).
Intestinal calcium absorption in adult VDR-null mice is normal. To determine the effect of VDR inactivation on intestinal calcium absorption, adult VDR(-/-) and wild-type mice (3 mo old) were administered 45 CaCl 2 by oral gavage, and the isotope in the whole gastrointestinal tract as well as in femurs and serum was determined after 0, 90, 180, and 360 min. The distribution of 45 Ca in these tissues was presented as the percentage of the dose administered. As shown in Fig. 3 , 45 Ca disappeared from the intestine over time, but no statistical difference was observed at each time point between VDR(-/-) and wild-type mice (Fig. 3A) , suggesting the rate of intestinal calcium absorption was similar in VDR(-/-) and wild-type mice. However, dramatic differences were seen between VDR(-/-) and wild-type mice in the appearance of 45 Ca in both the sera and femurs at 90, 180, and 360 min (Fig. 3, B and  C) . In both genotypes, the accumulation of 45 Ca in the serum was maximal at 90 min and gradually declined afterward, whereas the accumulation in the femurs increased over time, with the maximum at 360 min. Compared with VDR(-/-) mice, the amount of 45 Ca in the sera and femurs was Ն3-4 times higher in wildtype mice (Fig. 3, B and C) . These results suggested a more rapid renal excretion of calcium in VDR(-/-) mice.
Calcium conservation in VDR-null mice is impaired. To determine the effect of VDR inactivation on renal calcium handling, urinary concentrations of calcium, phosphorus, and creatinine were determined in 3-moold VDR(-/-) and wild-type mice. As shown in Fig. 4 , despite the hypocalcemic status of VDR(-/-) mice, their urinary calcium concentration was identical to that of wild-type mice. When VDR(-/-) mice were fed the HCaLac diet for 1 wk, which normalized the serum ionized calcium level (data not shown), their urinary calcium excretion was two times higher than that of wild-type mice fed the same diet (Fig. 4A) . However, the urinary phosphorus content was not different between VDR(-/-) and wild-type animals with or without the dietary treatment (Fig. 4B) .
DISCUSSION
In this report, we examined the effects of VDR disruption on the expression of CaBP-D9k and CaBPD28k as well as calcium metabolism in the intestine and kidney. Consistent with our previous observation on CaBP mRNA levels (32), we have shown here that VDR inactivation partially reduced duodenal CaBPD9k expression and virtually abolished renal CaBPD9k expression at both the mRNA and protein levels but had only a modest effect on renal CaBP-D28k expression. These data clearly demonstrate that, in the mouse kidneys, CaBP-D9k, but not CaBP-D28k, is highly regulated by the VDR-mediated action of 1,25(OH) 2 D 3 .
Given the extensive evidence that, in vivo, CaBPD9k was highly responsive to 1,25(OH) 2 D 3 status (8, 19, 25, 29, 35) , the 90% reduction in renal CaBP-D9k expression in VDR(-/-) mice was largely expected. The result confirms the role of VDR as a major regulator for renal CaBP-D9k expression. The 50% reduction in duodenal CaBP-D9k expression in the mutant mice suggests that, in addition to VDR, other tissue-specific factors may also be important for intestinal CaBP-D9k expression. This notion is supported by recent studies that demonstrated the involvement of caudal-related homeobox factor-2 and insulin promoter factor-1/ pancreatic duodenal homeobox factor-1 in the regulation of the intestinal CaBP-D9k gene (5, 17) . In fact, the molecular basis for the regulation of CaBP-D9k gene expression by 1,25(OH) 2 D 3 is not yet completely clear, as the previously identified VDRE in the CaBPD9k gene promoter (18) was not included in a DNA fragment from the same promoter that conferred 1,25(OH) 2 D 3 responsiveness, and deletion of this putative VDRE did not affect the responsiveness of CaBPD9k gene expression to 1,25(OH) 2 D 3 in transgenic mice (16, 17) . Further studies are required to clarify the mechanism of 1,25(OH) 2 D 3 control of CaBP-D9k gene expression.
The effect of VDR ablation on the expression of renal CaBP-D28k was not consistent with previous observations that CaBP-D28k was barely detectable in vitamin D-deficient animals (25, 43) and was highly inducible upon 1,25(OH) 2 D 3 administration (25, 29, 43) . This discrepancy could be due to species difference (rat vs. mouse) or to the possibility that 1,25(OH) 2 D 3 may have a VDR-independent effect on renal CaBP-D28k. The observation that a 50% reduction in CaBP-D28k occurred only in younger, but not in older, VDR(-/-) mice is intriguing, but the basis for this seemingly age- related VDR dependence is not clear. However, the expression of CaBP-D28k in the brain was constitutive and unaltered in both VDR(-/-) and vitamin D-deficient animals (unpublished data) (32, 43) , confirming that brain CaBP-D28k is not regulated by 1,25(OH) 2 D 3 .
VDR inactivation in both mice and humans results in hypocalcemia (31, 33) . In VDR-null mice, which are rachitic, calcium depletion may result mainly from impaired intestinal calcium absorption, impaired renal calcium reabsorption, or both. Thus the intestinal and renal contribution to hypocalcemia was examined in the present study. The oral gavage method (34) was chosen to assess total intestinal calcium absorption, because it is physiologically more relevant than other methods (e.g., the in vivo ligated loop method). We observed that the rate of 45 Ca disappearance from the intestine was virtually identical in VDR-null and wildtype mice but that the accumulation of 45 Ca in the serum and bone was much lower in VDR-null mice (Fig. 3) . The low serum and bone 45 Ca levels are consistent with the fact that the mutant mice are hypocalcemic, but the result of intestinal 45 Ca disappearance suggests that total calcium absorption in adult VDRnull mice is virtually normal, despite a 50% reduction in duodenal CaBP-D9k expression ( Fig. 2A) . It is known that intestinal calcium absorption is mediated by an active, calbindin-dependent, transcellular calcium transport in the duodenum and a passive, calbindin-independent, paracellular process that prevails in jejunum and ileum (10, 26) . Therefore, VDR inactivation may reduce the active duodenal calcium transport, as reported in a preliminary study (39) , but it seems to have little effect on the total intestinal calcium absorption under our experimental conditions. The passive, paracellular pathway may somehow compensate for the reduction in the calbindin-mediated transport. It is possible that the high serum 1,25(OH) 2 D 3 level in VDR-null mice (31, 44) may increase the intestinal paracellular calcium transport (12) .
The observation of normal calcium absorption but lower serum 45 Ca accumulation in VDR-null mice suggests a renal leak or decreased tubular calcium reabsorption. Consistent with this notion, the urinary calcium excretion in VDR-null mice is inappropriately high while they are hypocalcemic (31) and increases even further after 1 wk of a high-calcium diet (Fig. 4) . These results strongly suggest that renal calcium conservation is impaired in VDR-null mice, which contributes to the sustained hypocalcemia seen in these mice.
In normal adult animals, a major portion (Ͼ90%) of filtered calcium in the kidney is reabsorbed, and only a small fraction (2-5%), which is equal to the amount of calcium absorbed from the intestine, is excreted into the urine to maintain a calcium balance. In the distal nephron, tubular calcium transport is mediated through an active, ATP-dependent, transcellular process that may involve either CaBP-D9k, CaBP-D28k, or both, which may facilitate calcium movement from the apical to the basolateral membranes (9, 11, 26) . It is known that both parathyroid hormone (PTH) and 1,25(OH) 2 D 3 upregulate calcium reabsorption in the nephron. PTH directly increases calcium influx into the tubular epithethial cells (4), and 1,25(OH) 2 D 3 may increase PTH-dependent calcium uptake (22) , as well as directly increasing calcium transport by stimulating the gene expression of renal CaBPs (8, 14) . The colocalization of CaBP-D9k and CaBP-D28k in the epithelial cells of the distal tubules suggests that both may be involved in transcellular calcium transport (6, 7, 14, 36) . It has been reported that urinary calcium excretion is not related to the cytosolic CaBP-D28k concentration in the distal tubules (24) , and CaBP-D28k-null mice have normal calcium and phosphate levels and no compensatory elevation of CaBP-D9k (1). These data suggest that CaBP-D28k may play a less important role in calcium homeostasis. However, in a preliminary report, when the CaBP-D28k-null mice were fed a high-calcium diet for 4 wk, increased urinary calcium excretion was observed (40) . In the present study, we found that adult VDR-null mice are unable to retain filtered calcium efficiently, despite the fact that these mutant mice have a much higher serum PTH level (31) , which favors renal calcium reabsorption. This finding is associated with the observation that adult VDR-null mice express 90% of the normal level of CaBP-D28k but only 10% of CaBP-D9k in the kidney (Fig. 2, C-F) . These data suggest that CaBP-D9k may be an important mediator of calcium transport in the distal tubule and support the notion that CaBP-D28k is less critical in calcium homeostasis. It is also possible that CaBPD9k is a regulatory component in renal calcium transport, whereas CaBP-D28k is a constitutive component that maintains the basal calcium reabsorption.
However, given the complexity of renal calcium transport and metabolism (21) , it may be an oversimplification to attribute the hypercalcuria seen in VDRnull mice solely to the reduced renal CaBP-D9k level.
Other factors, such as changes in bone turnover or glomerular filtration rate or alterations in the expression of other genes involved in renal calcium metabolism (21) , may also contribute to this abnormality. Although a recent study has suggested that the bone turnover in VDR-null mice is not different from the bone turnover in wild-type mice (2), more detailed studies of bone and renal calcium handling are required before definitive conclusions can be reached.
In summary, our data demonstrated that, in the murine kidneys, CaBP-D9k, but not CaBP-D28k, is highly regulated by 1,25(OH) 2 D 3 . The data also suggest that impaired calcium conservation in the kidney may contribute to the development of hypocalcemia in VDR-null mice and that CaBP-D9k may play an important role in calcium reabsorption in the kidney.
